You can:
Name | Melanocortin receptor 3 |
---|---|
Species | Homo sapiens (Human) |
Gene | MC3R |
Synonym | MC3-R melanocortin receptor 3 MC3 receptor gamma-MSH receptor |
Disease | Sexual dysfunction; Obesity; Type 2 diabetes |
Length | 323 |
Amino acid sequence | MNASCCLPSVQPTLPNGSEHLQAPFFSNQSSSAFCEQVFIKPEVFLSLGIVSLLENILVILAVVRNGNLHSPMYFFLCSLAVADMLVSVSNALETIMIAIVHSDYLTFEDQFIQHMDNIFDSMICISLVASICNLLAIAVDRYVTIFYALRYHSIMTVRKALTLIVAIWVCCGVCGVVFIVYSESKMVIVCLITMFFAMMLLMGTLYVHMFLFARLHVKRIAALPPADGVAPQQHSCMKGAVTITILLGVFIFCWAPFFLHLVLIITCPTNPYCICYTAHFNTYLVLIMCNSVIDPLIYAFRSLELRNTFREILCGCNGMNLG |
UniProt | P41968 |
Protein Data Bank | N/A |
GPCR-HGmod model | P41968 |
3D structure model | This predicted structure model is from GPCR-EXP P41968. |
BioLiP | N/A |
Therapeutic Target Database | T76846 |
ChEMBL | CHEMBL4644 |
IUPHAR | 284 |
DrugBank | N/A |
Name | CHEMBL2113028 |
---|---|
Molecular formula | C35H54FN5O5 |
IUPAC name | tert-butyl (2S)-2-[[(2R)-1-[4-(tert-butylcarbamoyl)-4-cyclohexylpiperidin-1-yl]-3-(4-fluorophenyl)-1-oxopropan-2-yl]carbamoyl]piperazine-1-carboxylate |
Molecular weight | 643.845 |
Hydrogen bond acceptor | 7 |
Hydrogen bond donor | 3 |
XlogP | 4.8 |
Synonyms | (S)-1-Methyl-piperazine-2-carboxylic acid [(R)-2-(4-tert-butylcarbamoyl-4-cyclohexyl-piperidin-1-yl)-1-(4-fluoro-benzyl)-2-oxo-ethyl]-amide; dihydrochloride BDBM50157320 CHEMBL558814 |
Inchi Key | AUJXVLHOWUBHBM-IZLXSDGUSA-N |
Inchi ID | InChI=1S/C35H54FN5O5/c1-33(2,3)39-31(44)35(25-10-8-7-9-11-25)16-19-40(20-17-35)30(43)27(22-24-12-14-26(36)15-13-24)38-29(42)28-23-37-18-21-41(28)32(45)46-34(4,5)6/h12-15,25,27-28,37H,7-11,16-23H2,1-6H3,(H,38,42)(H,39,44)/t27-,28+/m1/s1 |
PubChem CID | 71449119 |
ChEMBL | CHEMBL2113028 |
IUPHAR | N/A |
BindingDB | N/A |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand is heavier than 500 daltons. |
Parameter | Value | Reference | Database source |
---|---|---|---|
cAMP accumulation | 10.0 % | PMID15582434 | ChEMBL |
zhanglabzhanggroup.org | (734) 647-1549 | 100 Washtenaw Avenue, Ann Arbor, MI 48109-2218